How Individuals Seeking Help for Substance Use Disorder Adjusted to Virtual 12-Step Meetings During the COVID-19 Pandemic.  Hassett-Walker C.  Inquiry. 2025 Jan-Dec;62:469580251320767. doi: 10.1177/00469580251320767. PMID: 40017449; PMCI…

Patient and clinician experiences with the implementation of telemedicine and related adaptations in office-based buprenorphine treatment during the COVID-19 pandemic: a qualitative study.  Davoust M, Bazzi AR, Blakemore S, Blodgett J, Cheng A…

Trends of Buprenorphine Prescribing for Opioid Dependence Before and During the Early and Later Part of the COVID-19 Pandemic: A Study From a Large, Publicly Funded Opioid Agonist Treatment Service in India.  Ghosh A, Basu D, Kaur S, Naik SS…

Use of Diverted Buprenorphine by Individuals Initiating Telehealth Opioid Use Disorder Treatment.  Weiner SG, Miller EN, Clear B.  Subst Use Misuse. 2025;60(3):442-445. doi: 10.1080/10826084.2024.2434006. Epub 2024 Dec 1. PMID: 39618055…

Impact of COVID-19 on Substance Use Disorder Treatment: Examining the Influence of In-Person and Telehealth Intervention on Outcomes Using Real-World Data.  Mancheño-Velasco C, Narváez-Camargo M, Dacosta-Sánchez D, de la Rosa-Cáceres A, Lozano…

How Has the COVID-19 Pandemic Impacted Addiction Services? A Study of the Different Periods of the Pandemic and Patient Treatment Follow-up Over 1 Year.  Narváez-Camargo M, Mancheño-Velasco C, Díaz-Batanero C, Fernández-Calderón F, Lozano OM.&…